SCHEMBL17351

SCHEMBL17351

CCCN(C[C@@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1)S(C)(=O)=O

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.66
GCKR Q14397 8/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16036 0.91 GCK (0.71) GCKGCKR
SCHEMBL17361 0.91 GCK (0.71) GCKGCKR
SCHEMBL23908 0.91 GCKR (0.64) GCKGCKR
SCHEMBL17980 0.91 GCK (0.62) GCKGCKR
SCHEMBL12079932 0.90 GCK (0.66) GCKGCKR
SCHEMBL17478 0.90 GCKR (0.70) GCKGCKR
SCHEMBL12078342 0.90 GCKR (0.70) GCKGCKR
SCHEMBL18959 0.90 GCKR (0.70) GCKGCKR
SCHEMBL18944 0.90 GCK (0.66) GCKGCKR
SCHEMBL16641 0.90 GCK (0.66) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed